1 / 8

Idiopathic Membranous Nephropathy Treatment Market Analysis-2027

u201cCoherent Market Insights u201cIDIOPATHIC MEMBRANOUS NEPHROPATHY TREATMENT MARKET u2013 GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027u2033

SANJAYCMI
Download Presentation

Idiopathic Membranous Nephropathy Treatment Market Analysis-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. IDIOPATHIC MEMBRANOUS NEPHROPATHY TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Idiopathic Membranous Nephropathy Treatment Market - Overview Global Idiopathic Membranous Neuropathy Treatment Market Regional Analysis North America is expected to hold the dominant position in the global Idiopathic Membranous Nephropathy Market due to high prevalence of idiopathic membranous nephropathy in the region. According to the clinical journal of American Society of Nephrology, 2017, around 12 million people in the age group of 50 to 60 suffer from idiopathic membranous nephropathy every year in North America. For instance, according to the Biomedical Research International, 2017, North America, Europe and Asia Pacific regions witness high prevalence of idiopathic membranous nephropathy. Membranous nephropathy occurs when the blood vessels in the nephron (filters) of the kidney get damaged. This leads to proteinuria, that is, leakage of proteins in the urine due to thickening of the walls of the blood vessels which increase the chances of kidney failure. There is no specific treatment available for the condition but if treated correctly, it can be controlled. The symptoms include swelling in the legs, weight gain, poor appetite, high cholesterol, fatigue, acute and chronic kidney failure. Two types of membranous nephropathy are primary and secondary membranous nephropathy. Primary membranous nephropathy occurs when the body‘s antibodies attack healthy cells in the body, and secondary membranous nephropathy occurs due to conditions like hepatitis B, hepatitis C, syphilis, internalization of medications like NSAIDs, gold salts, tumors etc. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing- insight/idiopathic-membranous-nephropathy-treatment-market-3383 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Global Idiopathic Membranous Nephropathy Treatment Market Drivers Leading manufacturers are engaged in the manufacture of drugs for treatment of idiopathic membranous nephropathy. Increasing research and development activities related to newer treatment options is expected to support the global idiopathic membranous nephropathy treatment market growth over the forecast period. For instance, Novartis International AG has a potential drug, LNP023 (orally active factor B inhibitor), in phase II of clinical trials. The study is expected to be completed in June 2021. The drug is being tested on patients suffering from idiopathic membranous nephropathy. Moreover, National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network and GlaxoSmithline are currently working together to understand the effect of combination therapy involving belimumab and rituximab on patients suffering from idiopathic membranous nephropathy. According to the New England Journal of Medicine, 2019, a clinical trial performed on patients suffering from membranous nephropathy to compare the efficacy of rituximab and cyclosporine, showed that 60% of the patients responded positively to the rituximab treatment. The remaining 40% patients did not show any response to the treatment. Therefore, there is more scope for developing alternative immunosuppressive therapies for a minor group of patients suffering from idiopathic membranous nephropathy and resistant to rituximab treatment. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3383 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Global Idiopathic Membranous Neuropathy Treatment Market Restraints According to the journal of American Society of Nephrology, 2012, some side effects have been reported in association with the drugs prescribed for idiopathic membranous nephropathy. For instance, osteoporosis (decrease in the muscle activity of the patients), hyperglycemia, secondary diabetes, impairment of fertility and teratogenic effects during pregnancy are some of the side-effects. Rituximab, has not been approved by U.S. FDA till date for nephropathy. However, it has been approved for treatment of other diseases like rheumatoid arthritis, lupus, vasculitis, and dermatomyositis. These factors are expected to limit growth of the global idiopathic membranous nephropathy treatment market over the forecast period. Most manufacturers are headquartered in the U.S. such as Baxter Healthcare Corporation, Bristol – Myers Squibb Company, Merck and Co Inc. and Mylan Pharmaceutical ltd. Therefore introduction of existing as well as new treatment options across North America is expected to drive the global idiopathic membranous nephropathy treatment market growth over the forecast period. Global Idiopathic Membranous Nephropathy Treatment Market Key Players Some of the key players operating in the global idiopathic membranous nephropathy treatment market growth are Aspen Global Inc., Astellas Pharma Inc., Baxter Healthcare Corporation, Bristol – Myers Squibb Company, Merck and Co Inc., and Mylan Pharmaceutical ltd., Novartis International AG, Pfizer Inc. Roche, Sigma Aldrich Corporation. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3383 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related